Literature DB >> 2693708

Inhibition of macrophage phagocytic activity by SV-IV, a major protein secreted from the rat seminal vesicle epithelium.

F Galdiero1, M A Tufano, L De Martino, C Capasso, R Porta, G Ravagnan, G Peluso, S Metafora.   

Abstract

The protein SV-IV, one of the major secretory proteins produced by the rat seminal vesicle epithelium, has been found to possess a marked ability to inhibit in vitro the phagocytic properties of activated peritoneal rat macrophages, by a mechanism that apparently involves phagocytes and target cells. Although SV-IV is a substrate for transglutaminase (TGase), an enzyme secreted by activated macrophages, TGase does not seem to play any significant role either in the binding of the protein to the cells participating in the phagocytic process or in the inhibition of macrophage phagocytosis by SV-IV. The significance of the findings in relation to the reproductive process and their possible clinical implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693708     DOI: 10.1016/0165-0378(89)90056-9

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  2 in total

1.  The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates alpha-thrombin activity: potential clinical implications.

Authors:  Marilena Lepretti; Susan Costantini; Gaetano Ammirato; Gaia Giuberti; Michele Caraglia; Angelo M Facchiano; Salvatore Metafora; Paola Stiuso
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

2.  Effect of protein SV-IV on experimental Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Caterina Romano-Carratelli; Concetta Bentivoglio; Immacolata Nuzzo; Nunzia Benedetto; Elisabetta Buommino; Anna Cozzolino; Maria Cartenì; Francesco Morelli; Maria Rosaria Costanza; Biancamaria Metafora; Vittoria Metafora; Salvatore Metafora
Journal:  Clin Diagn Lab Immunol       Date:  2002-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.